Development of commercial gene-expression-based signatures: review of the scientific strategies

Author： Ashton-Chess Joanna   Cervino Alessandra CL  

Publisher： Future Medicine

ISSN： 1741-0541

Source： Personalized Medicine, Vol.8, Iss.3, 2011-05, pp. : 253-269

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Applications of Gene Expression Signatures in Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 2-8

Karger

Access to resources Recommend Favorite

Acute Myeloid Leukemia Subgroups Identified by Pathway-Restricted Gene Expression Signatures

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 77-89

Karger

Access to resources Recommend Favorite

Commercial development of stem cell technology: lessons from the past, strategies for the future

By Martin Paul A   Coveney Catherine   Kraft Alison   Brown Nik   Bath Philip  

Regenerative Medicine, Vol. 1, Iss. 6, 2006-11 ,pp. : 801-807

Future Medicine

Access to resources Recommend Favorite

Three clinical variants of gastroesophageal reflux disease form two distinct gene expression signatures

By Ostrowski Jerzy   Rubel Tymon   Wyrwicz Lucjan   Mikula Michal   Bielasik Andrzej   Butruk Eugeniusz   Regula Jaroslaw  

Journal of Molecular Medicine, Vol. 84, Iss. 10, 2006-10 ,pp. : 872-882

Springer Publishing Company

Access to resources Recommend Favorite

ALS & PLS fibroblasts as cell models for sporadic disease

By  

NEUROPATHOLOGY & APPLIED NEUROBIOLOGY, Vol. 41, Iss. 2, 2015-02 ,pp. : 201-226

John Wiley & Sons Inc

Access to resources Recommend Favorite